Baumer

Baumer OCF Growth YoY

The Year-over-Year Operating Cash Flow Growth of Baumer (BALM4.SA) as of Nov 9, 2026 is 29.17 %. In the previous year, Year-over-Year Operating Cash Flow Growth was 666.04 % — a change of -95.62% (lower).

OCF Growth YoY

29.17 %

YoY

-95.62%

Last updated:

Year-over-Year Operating Cash Flow Growth of Baumer is 2024 29.17 % . Year-over-Year Operating Cash Flow Growth of Baumer was 2023 666.04 % . It decreases by -95.62% lower compared to the previous year.

The Baumer OCF Growth YoY history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Growth YoY
Date
OCF Growth YoY
Jan 1, 2017
622.45 BRL
Jan 1, 2018
-151.86 BRL
Jan 1, 2019
606.13 BRL
Jan 1, 2020
81.23 BRL
Jan 1, 2021
-33.01 BRL
Jan 1, 2022
-82.23 BRL
Jan 1, 2023
666.04 BRL
Jan 1, 2024
29.17 BRL
The Baumer OCF Growth YoY history
YEAROCF Growth YoYYoY
29.17 %-95.62%
666.04 %-909.93%
-82.23 %+149.12%
-33.01 %-140.64%
81.23 %-86.60%
606.13 %-499.14%
-151.86 %-124.40%
622.45 %-843.84%
-83.68 %+1,138.98%
-6.75 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Baumer Stock analysis

What does Baumer do? Baumer SA generates revenue through the sale of medical equipment and solutions across its four business units. The Orthopedic unit produces and sells orthopedic implants and instruments, while the Hospital unit manufactures equipment for hospitals and industries including pharmaceutical, chemical, cosmetic, and food sectors. The Genius unit focuses on biomaterials, and the Brown unit supplies laundry equipment for hospitals, industrial, and hotel settings. The company's subsidiaries, Hospitalar Sul Ltda and Waldsea Investment SA, support its operations as of December 31, 2011. The primary buyers of Baumer SA's products include hospitals, pharmaceutical companies, chemical manufacturers, cosmetic firms, and food industry businesses. Additionally, industrial and hotel sectors purchase the laundry equipment from the Brown unit. The company's technical assistance services for medical apparatus also contribute to its revenue stream. Baumer SA's business model relies on direct sales of its specialized equipment and solutions to healthcare and industrial clients. The firm's product portfolio spans orthopedic care, hospital infrastructure, biomaterials, and laundry systems, catering to both medical and non-medical industrial applications. This diversified approach allows the company to serve multiple segments within the health and industrial markets. Baumer is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Baumer stock

Year-over-Year Operating Cash Flow Growth of Baumer is 29.17 % in 2024.

On Eulerpool you can find the complete historical development of Year-over-Year Operating Cash Flow Growth Baumer since 2006 – with annual values, charts, and detailed analysis.

OCF growth measures the percentage change in operating cash flow. Growing OCF indicates improving cash generation from core operations.

To evaluate Year-over-Year Operating Cash Flow Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Operating Cash Flow Growth.

Year-over-Year Operating Cash Flow Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Operating Cash Flow Growth's Baumer historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Baumer

All Key Metrics — Baumer